Dosing Colistimethate Every 8 h Results in Higher Plasma Concentrations of Active Colistin Than Every 12-Hourly Dosing without Increase in Nephrotoxicity: A Phase 1 Pharmacokinetics Trial in Healthy Adult Volunteers Article (Web of Science)

Open Access

cited authors

  • Yendewa, George A.; Griffiss, John McLeod; Gray, Wesley A.; Healen, Amanda; Proskin, Howard M.; Fulton, Scott A.; O'Riordan, Mary Ann; Hoppel, Charles; Blumer, Jeffrey L.; Salata, Robert A.

publication date

  • April 1, 2022

webpage

published in

category

keywords

  • antimicrobial resistance
  • colistin
  • gram-negative bacteria
  • pharmacokinetics

volume

  • 11

issue

  • 4